Queen Elizabeth II honours UK university for Parkinson’s research

News

Author: Roisin McCormackPublished: 5 December 2019

Prep: Cook: Serves:

Queen Elizabeth II visiting a research centre

A neuroscience research centre at the University of Sheffield, UK, has been recognised by Queen Elizabeth II for improving the lives of patients living with neurodegenerative conditions, including Parkinson’s.

The Sheffield Institute for Translational Neuroscience, which is based at the university, uses emerging developments in neuroscience to create innovative new approaches to treating brain conditions.

The prestigious Queen’s Anniversary Prize was awarded at St James’s Palace, London. The institute was commended for its development of Parkinson’s drug discovery programmes.

The honour is awarded to UK universities who exhibit groundbreaking and innovative approaches to research – with beneficial results at local, national and global levels.

Professor Koen Lamberts, president and vice-chancellor for the University of Sheffield, said: “As well as making life-changing discoveries today, The Sheffield Institute for Translational Neuroscience is nurturing the next generation of talented neuroscience students, whose research will lead to pioneering treatments for those living with neurological diseases.”

New Parkinson’s health app to track symptoms more accurately

Last Month

Next Month

Go Back

Share this story

Comments

Interviews

Meet the fashion graduate designing adaptive clothing for people with Parkinson’s

Monika Dugar tells us about her project aiming to improve mobility

Episodes

Podcast: Living with ‘advanced’ Parkinson’s disease

From coping with changing symptoms to keeping a positive attitude

“People love competition, don’t they?”

Take part in an exercise initiative for Parkinson’s disease

A “revolutionary” step in stem cell therapy for Parkinson’s disease?

Scientists in China have developed a method to help improve stem cell research in mice models of Parkinson’s – which could potentially lead to promising new treatments. The researchers, based at the Chinese Academy of Sciences, identified two cell surface markers of dopamine neurons, which are reduced in Parkinson’s. They injected cells with these markers into the brains of the mice and found that this resulted in “higher therapeutic potency” for improving motor symptoms of the condition. As part of their research, the team also worked to control the variability of donor cells, to help improve therapeutic outcomes for Parkinson’s cell therapy. The researchers, whose study was published in ‘The Journal of Clinical Investigation’, described the findings as a “revolutionary step on the road towards more effective and safer stem cell therapies”.

Could frequent nightmares be an early sign of Parkinson’s disease?

A new study has suggested that experiencing recurrent nightmares and bad dreams could be an early symptom of Parkinson’s disease. Researchers from the University of Birmingham, UK, used data from an existing US study that followed 3818 men, aged 67 or older, over a period of 12 years. Participants who reported experiencing bad dreams at least once a week were followed up. During the follow up, 91 people were diagnosed with Parkinson’s. The results suggested that participants who had frequent bad dreams were twice as likely to develop the condition as those who did not. Commenting on the study, lead author Dr Abidemi Otaiku said: “While we need to carry out further research, identifying the significance of bad dreams and nightmares could indicate that individuals who experience changes to their dreams in older age – without any obvious trigger – should seek medical advice.”

More than £2m awarded to research on mitochondria and Parkinson’s disease

Researchers at UK biotech startup NRG Therapeutics are developing potential treatments that may help slow the progression of Parkinson’s by protecting the mitochondria – a part of every human cell that works to power chemical reactions. The company has now received a £2.68m award from government-backed agency Innovate UK to continue its research. Their research built upon previous findings that damage to mitochondria in the substantia nigra – an area of the brain associated with dopamine – may be linked to Parkinson’s. The scientists developed molecules that keep a ‘pore’ in the mitochondria closed, which stops calcium flowing into it, preventing a process that eventually ruptures the powerhouse of the cell and leads to its death. The new funding award follows previous investment from Parkinson’s UK and the Michael J Fox Foundation.

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Email
This field is for validation purposes and should be left unchanged.

Queen Elizabeth II honours UK university for Parkinson’s research

News

Author: Roisin McCormackPublished: 5 December 2019

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Interviews

Meet the fashion graduate designing adaptive clothing for people with Parkinson’s

sponsored article

Episodes

Podcast: Living with ‘advanced’ Parkinson’s disease

Interviews

“People love competition, don’t they?”

A “revolutionary” step in stem cell therapy for Parkinson’s disease?

Could frequent nightmares be an early sign of Parkinson’s disease?

More than £2m awarded to research on mitochondria and Parkinson’s disease

{title}

Subscribe

Queen Elizabeth II honours UK university for Parkinson’s research

News

Author: Roisin McCormackPublished: 5 December 2019

Last Month

Next Month

Share this story

Comments

Related articles

Interviews

Meet the fashion graduate designing adaptive clothing for people with Parkinson’s

sponsored article

Episodes

Podcast: Living with ‘advanced’ Parkinson’s disease

Interviews

“People love competition, don’t they?”

A “revolutionary” step in stem cell therapy for Parkinson’s disease?

Could frequent nightmares be an early sign of Parkinson’s disease?

More than £2m awarded to research on mitochondria and Parkinson’s disease

{title}

Subscribe

Sign in